Manahan, Eric R.
Kuerer, Henry M.
Sebastian, Molly
Hughes, Kevin S.
Boughey, Judy C.
Euhus, David M.
Boolbol, Susan K.
Taylor, Walton A.
Article History
Received: 18 April 2019
First Online: 24 July 2019
Disclosures
: Dr. Kevin Hughes reports honoraria from Focal Therapeutics, 23andMe, and is a founder of and has a financial interest in CRA Health (Formerly Hughes RiskApps); Mark Robson reports honoraria (advisory) from AstraZeneca, and consulting or advisory from: McKesson, AstraZeneca, Merck (uncompensated), research funding from: AstraZeneca (Institution), Myriad (Institution, in-kind), Invitae (Institution, in-kind), AbbVie (institution), Tesaro (institution), Medivation (institution) and travel or accommodation or expenses from AstraZeneca; Dr. Banu Arun reports research funding from: AstraZeneca (institution), Invitae (institution), AbbVie (institution), and PharmaMar (institution).